Outcomes in systemic lupus erythematous (SLE) patients treated with belimumab in clinical practice settings: results from the observe study in switzerland

被引：0
|
作者：
von Kempis, J. [1 ]
Dutsch, S. [2 ]
Reuschling, N. [1 ]
Villiger, R. [3 ]
Vallelian, F. [4 ]
Schaer, D. J. [4 ]
Mueller, R. B. [1 ]
机构：
[1] Kantonsspital St Gallen, St Gallen, Switzerland
[2] GlaxoSmithKline AG, Munchenbuchsee, Switzerland
[3] Inselspital Bern, Bern, Switzerland
[4] Univ Spital Zurich, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2017年 / 147卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 3
引用
收藏
页码：4S / 4S
页数：1
相关论文
共 50 条
  • [21] Real-World Effectiveness of Intravenous Belimumab on Clinical Outcomes in Patients With Systemic Lupus Erythematosus in Saudi Arabia : The OBSErve Observational Study
    Al-Homood, Ibrahim Abdulrazag
    Almaghlouth, Ibrahim
    Asiri, Alhussain Mohammed
    Hamdy, Hanan
    Alhammad, Ali
    Mustafa, Alaa
    Othman, Mohamed
    Khamashta, Munther
    Elfishawy, Tamer
    Teichman, Lindsey
    dos Santos, Debora
    Queiroz, Juliana Domenico
    Noibi, Saeed
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2025, 17 : 33 - 45
  • [22] Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
    Dooley, M. A.
    Houssiau, F.
    Aranow, C.
    D'Cruz, D. P.
    Askanase, A.
    Roth, D. A.
    Zhong, Z. J.
    Cooper, S.
    Freimuth, W. W.
    Ginzler, E. M.
    LUPUS, 2013, 22 (01) : 63 - 72
  • [23] HEALTH CARE RESOURCE UTILIZATION PATTERNS ASSOCIATED WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM OBSERVE STUDY IN THE UNITED STATES
    Narayanan, S.
    Dall'Era, M.
    Collins, C.
    Dennis, G.
    Oglesby, A. K.
    McGuire, M.
    Pappu, R.
    Molta, C. T.
    Keenan, G.
    VALUE IN HEALTH, 2013, 16 (03) : A125 - A126
  • [24] Favorable pregnancy outcomes in two patients with systemic lupus erythematosus treated with belimumab
    Wei, Si-Ru
    Zhu, Zhen-Zhen
    Xu, Jia
    Mo, Han-You
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (01) : 154 - 156
  • [25] COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study
    Wu, Yinlan
    Li, Yanhong
    Wu, Tong
    Huang, Deying
    Wu, Jianhong
    Zhang, Weihua
    Jiang, Xuejun
    Yao, Chaoqiong
    Liang, Xiuping
    Cheng, Lu
    Liao, Zehui
    Xu, Fang
    Tan, Chunyu
    Liu, Yi
    Herrmann, Martin
    IMMUNOLOGIC RESEARCH, 2024, 72 (03) : 418 - 429
  • [26] PHARMACOKINETICS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Sheikh, S. Z.
    Fox, N. L.
    Hammer, A. E.
    Struemper, H.
    Groark, J.
    Roth, D.
    Gordon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 297 - 298
  • [27] EFFECT OF BELIMUMAB ON CLINICAL PROFILES AND DAILY LIVING SCORE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Ishizuka, T.
    Fujioka, K.
    Tangiku, M.
    Tani, H.
    Maeda, A.
    Kato, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1471 - 1471
  • [28] CHARACTERISTICS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) CURRENTLY EXPERIENCING FLARES IN CLINICAL PRACTICE SETTINGS IN EUROPE (EU)
    Narayanan, S.
    Hutchings, R.
    Lu, Y.
    VALUE IN HEALTH, 2015, 18 (03) : A302 - A302
  • [29] EVALUATION OF USE OF BELIMUMAB IN CLINICAL PRACTICE SETTINGS (OBSERVE STUDY) IN SPAIN: HEALTH RESOURCE UTILIZATION AND LABOUR ABSENTEEISM
    Cortes, J.
    Andreu, J. L.
    Calvo, J.
    Garcia-Aparicio, A. M.
    Coronell, C. G.
    Diaz-Cerezo, S.
    VALUE IN HEALTH, 2014, 17 (07) : A534 - A534
  • [30] Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)
    Witt, M.
    Grunke, M.
    Proft, F.
    Baeuerle, M.
    Aringer, M.
    Burmester, G.
    Chehab, G.
    Fiehn, C.
    Fischer-Betz, R.
    Fleck, M.
    Freivogel, K.
    Haubitz, M.
    Koetter, I.
    Lovric, S.
    Metzler, C.
    Rubberth-Roth, A.
    Schwarting, A.
    Specker, C.
    Tony, H-P
    Unger, L.
    Wassenberg, S.
    Doerner, T.
    Schulze-Koops, H.
    LUPUS, 2013, 22 (11) : 1142 - 1149
12345